Your session is about to expire
← Back to Search
Patient open label intervention arm for Cystic Fibrosis
Study Summary
This trial will test a new device to help manage chronic abdominal pain in children with Cystic Fibrosis.
- Cystic Fibrosis
- Irritable Bowel Syndrome
- Chronic Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to become a participant in this clinical investigation?
"This clinical trial aims to recruit 20 minors between 11 and 18 years old who are suffering from chronic pain. Applicants should be native English speakers, familiar with the protocol of consenting, come from a variety of racial/ethnic backgrounds and both genders, have had at least 2 days per week abdominal discomfort for two months prior to participating in the study, obtain an average weekly abdominal score rating higher than 3 on a 0-10 point scale before enrollment into the experiment (and not due to any underlying organic cause) and continue until their eighteenth birthday if they turn eighteen during participation."
Are there any vacancies left in this clinical experiment?
"Clinicaltrials.gov data indicates that this research project is no longer recruiting new subjects, having initially been posted on November 1st 2022 and its last update occurring on October 19th 2022. However, there are presently 925 other trials actively seeking enrollees."
Does this research protocol accept participants aged sixty and above?
"This study requires that participants be between 11 and 18 years old, with 133 clinical trials listed for minors and 823 for adults above 65."
Share this study with friends
Copy Link
Messenger